Image

Neuropsychological Profiles and Musical Engagement in Parkinson's and Alzheimer's Disease

Neuropsychological Profiles and Musical Engagement in Parkinson's and Alzheimer's Disease

Recruiting
60 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this Multicenter observational pilot study is to Compare the specifics of musical engagement (behaviors related to music in everyday life) in subjects aged over 60 with Alzheimer s disease, Parkinson s disease and control subjects.

The main questions it aims to answer are:

  1. The description of different profiles of musical engagement in early-stage AD, in PD and in healthy elderly subjects.
  2. The extent of executive, mnestic and hedonic dysfunctions will impact differently on emotional engagement, autobiographical evocation and sensitivity to musical reward, and will therefore enable distinct profiles to be drawn up.

Participants will have an intervention consisting of an interview with a neuropsychologist lasting approximately 2 hours, including :

  • A semi-structured interview to check the participants eligibility and gather demographic data.
  • Neuropsychological tests and questionnaires will then be administered.
  • A relative of the study participant will help complete questionnaires.

Description

Music therapy appears to be highly relevant as a Non-Medication Intervention in Alzheimer s (AD) and Parkinson s disease (PD). It is said to reduce depressive symptoms following music therapy sessions in dementia . With regard to Parkinson s disease, music therapy brings benefits in terms of motor skills, communication, breathing and emotional aspects. Reviews point to the need to differentiate beneficial effects according to different pathologies.

To date, no study has investigated the evolution of sensitivity to musical reward in AD. Furthermore, no study has discriminated the evolution of musical engagement in several neurodegenerative pathologies.

Eligibility

Inclusion Criteria:

General inclusion criteria:

  • 60 years and older
  • French-speaking and volunteering for the study
  • Living at home with a relative

Alzheimer's disease inclusion criteria:

  • Biological diagnosis of probable Alzheimer's disease according to NINCDS-ADRDA criteria (McKhann et al., 1984)
  • MMSE greater than or equal to 20

Inclusion criteria Parkinson's disease :

  • Diagnosis of Idiopathic Parkinson's disease
  • MMSE greater than or equal to 20

Exclusion Criteria:

  • No known neurological pathologies (epilepsy and other non-degenerative CNS diseases) or psychiatric disorders (chronic psychosis and psychotic episodes)
  • Autistic disorders
  • History of stroke or head trauma
  • Unstable medical condition (cancer)
  • Subject unable to read and/or write
  • Hearing impairment without hearing aids
  • Refusal of consent after information
  • Persons unable to give consent, research carried out in emergency situations, etc.)
  • Non-affiliation with a social security scheme
  • Person deprived of liberty (by judicial or administrative decision, or forced hospitalization)
  • Person under legal protection (guardianship, curatorship, legal protection)
  • Person participating in another research project with an exclusion period still in progress

Study details
    Alzheimer Disease
    Early Onset
    Parkinsons Disease with Dementia
    Non Pharmacological Intervention

NCT06688968

University Hospital, Montpellier

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.